Rihim Pharma Consultancy Private Limited, a active private limited company, was established on 04 May 2010 in Delhi, Delhi, India. Engaging in preventive health services within the professional, scientific and technical sector, it holds CIN: U52100DL2010PTC202258. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.20 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Employing 7 professional, Its leadership includes Gautam Hasmukhrai Kamdar (Director), Ratna Thosani (Director), Nilesh Thosani (Director). It holds ₹1.35 Cr open charges and ₹1.21 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 518-519, Fifth Floor, Ring Road Mall, Manglam Place, Sec-03,, Delhi, Delhi, 110085.
U52100DL2010PTC202258
202258
04 May 2010
₹0.20 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Rihim Pharma Consultancy Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Gautam Hasmukhrai Kamdar | Director | 04 May 2010 | Current |
| Ratna Thosani | Director | 04 May 2010 | Current |
| Nilesh Thosani | Director | 04 May 2010 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Rihim Pharma Consultancy Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 24.16% increase. The company also saw a substantial improvement in profitability, with a 10.8% increase in profit. The company's net worth Soared by an impressive increase of 30.71%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Rihim Pharma Consultancy had a public holding of 15.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹13,540,200.00
₹12,089,200.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Sep 2023 | Others | ₹4.70 M | Open |
| 29 Jun 2021 | Axis Bank Limited | ₹7.99 M | Open |
| 21 Sep 2019 | Others | ₹0.85 M | Open |
| 17 Nov 2018 | Hdfc Bank Limited | ₹1.85 M | Satisfied |
| 26 Sep 2018 | Others | ₹4.74 M | Satisfied |
Explore comprehensive loan charge details -
Rihim Pharma Consultancy has a workforce of 7 employees as of Apr 24, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Rihim Pharma Consultancy, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rihim Pharma Consultancy's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge registered on 17 Nov 2018 via Charge ID 100224185 with Hdfc Bank Limited was fully satisfied on 25 Aug 2025. was documented.
The activity Rihim Pharma Consultancy Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity Rihim Pharma Consultancy Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was completed.
A charge registered on 21 May 2018 via Charge ID 100193207 with Hdfc Bank Limited was fully satisfied on 11 Oct 2023. was recorded as a recent event.
Progress on A charge with Others amounted to Rs. 4.70 M with Charge ID 100791012 was registered on 15 Sep 2023. was documented.
A charge registered on 26 Sep 2018 via Charge ID 100210403 with Others was fully satisfied on 14 Apr 2022. was recorded as a recent event.
The CIN of Rihim Pharma Consultancy Private Limited is U52100DL2010PTC202258.
Rihim Pharma Consultancy Private Limited is headquartered at 518-519, Fifth Floor, Ring Road Mall, Manglam Place, Sec-03,, Delhi, Delhi, 110085.
Rihim Pharma Consultancy Private Limited was incorporated on 04 May 2010.
The current directors of Rihim Pharma Consultancy Private Limited are
The primary industry of Rihim Pharma Consultancy Private Limited is Professional, Scientific And Technical.
Rihim Pharma Consultancy Private Limited is unlisted.
The authorized capital of Rihim Pharma Consultancy Private Limited is ₹0.20 M, and the paid-up capital is ₹0.10 M.
The compliance status of Rihim Pharma Consultancy Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX